These aids use satellite technology to locate a person who may have become disoriented and unable to navigate their way home or has wandered from their own familiar environment. Tracking devices can improve a person’s independence and support the carer, however the assessing health provider needs to evaluate risks associated with wandering and the need for personal freedom and the right to privacy.
Tracking devices are less likely to be applicable for entitled clients in the later stages of dementia.
Other simpler approaches should be trialled initially. Walking has substantial benefits however there are valid ethical issues to consider before prescribing a LMOS tracking device when a person is unable to give informed consent. Clinical records should reflect collaboration between entitled client, carer, treating medical doctor and specialists, allied health providers and any other relevant person.
A record of consent by the entitled client or Enduring Power of Attorney (Medical Treatment) is necessary.
May also be useful for managing clients with Acquired Brain Injury (ABI) resulting from trauma, disease, stroke, alcohol, drugs, hypoxia, degenerative neurological disease, Multiple Sclerosis, Huntington’s disease, Motor Neurone disease, Parkinson’s disease. ABI can affect a person’s cognitive, physical, emotional and independent function resulting in a mild to profound loss of independence.
The GP or Medical Specialist is responsible for ensuring a comprehensive assessment is conducted, such as using the Psychogeriatric Assessment Scales. The referral from the GP or Medical Specialist must specify type and stage of dementia, or ABI, and include relevant details of current co-morbidities and medication.
These aids use satellite technology to locate a person who may have become disoriented and unable to navigate their way home or has wandered from their own familiar environment. Tracking devices can improve a person’s independence and support the carer, however the assessing health provider needs to evaluate risks associated with wandering and the need for personal freedom and the right to privacy.
Tracking devices are less likely to be applicable for entitled clients in the later stages of dementia.
Other simpler approaches should be trialled initially. Walking has substantial benefits however there are valid ethical issues to consider before prescribing a LMOS tracking device when a person is unable to give informed consent. Clinical records should reflect collaboration between entitled client, carer, treating medical doctor and specialists, allied health providers and any other relevant person.
A record of consent by the entitled client or Enduring Power of Attorney (Medical Treatment) is necessary.
May also be useful for managing clients with Acquired Brain Injury (ABI) resulting from trauma, disease, stroke, alcohol, drugs, hypoxia, degenerative neurological disease, Multiple Sclerosis, Huntington’s disease, Motor Neurone disease, Parkinson’s disease. ABI can affect a person’s cognitive, physical, emotional and independent function resulting in a mild to profound loss of independence.
The GP or Medical Specialist is responsible for ensuring a comprehensive assessment is conducted, such as using the Psychogeriatric Assessment Scales. The referral from the GP or Medical Specialist must specify type and stage of dementia, or ABI, and include relevant details of current co-morbidities and medication.
Assessment form for the supply of Personal Response System – D9199